SBRA — Sabra Health Care REIT Income Statement
0.000.00%
Last trade - 00:00
- $3.23bn
- $5.60bn
- $647.51m
- 73
- 60
- 45
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 595 | 597 | 569 | 625 | 648 |
Cost of Revenue | |||||
Gross Profit | 509 | 490 | 452 | 482 | 470 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 520 | 449 | 501 | 587 | 555 |
Operating Profit | 74.8 | 148 | 68 | 37.3 | 92.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 72.4 | 139 | -111 | -76.4 | 15.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 69 | 138 | -113 | -77.6 | 13.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 69 | 138 | -113 | -77.6 | 13.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 69 | 138 | -113 | -77.6 | 13.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.718 | 0.706 | -0.413 | -0.044 | 0.406 |
Dividends per Share |